Table 1.

Characteristics of patients with thyroid cancer who would benefit from telemedicine versus in-person visits post-pandemic

Telemedicine visits	In-person visits
Patients with DTC or MTC who are ATA low-risk or intermediate-risk with excellent response to therapy; patients who live far from the hospital, including international patients; patient preference	Symptomatic patients; new patients; patients on clinical trials; patients with DTC or MTC who are ATA intermediate-risk with incomplete response to therapy or progressive disease; patients with DTC or MTC who are ATA high-risk; patients who lack technological skills or adequate internet service; patient preference

Abbreviations: ATA, American Thyroid Association; DTC, well-differentiated thyroid cancer; MTC, medullary thyroid cancer.